Jessica Vamathevan,
Centre for Therapeutic Target Validation (CTTV) Operations Director
As Operations Director, Jessica oversees the scientific management of a number of informatics and experimental target validation projects as well as ensuring the strategic deployment and operational translation of the CTTV, a public-private Consortium. Prior to this, Jessica was a Team Leader in Computational Biology, GlaxoSmithKline, Stevenage UK, working with discovery scientists in many therapeutic areas including Infectious Diseases, Respiratory, Immuno-Inflammation and Rare Diseases to deliver impactful bioinformatics projects. Before GSK, Jessica spent over six years at The Institute for Genomic Research (TIGR) in Maryland, USA working on many pathogen genome sequencing projects plus a year at the Wellcome Trust Sanger Institute in the human genome annotation team. She also taught as a Lecturer in Molecular Evolution at University College London. She holds a PhD in Bioinformatics from University College London, an MSc in Computer Science from Johns Hopkins University and a Bachelor of Medical Science from the University of Sydney.
|
|
|
